Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alan Lewis currently holds 25,590 shares of BIOMARIN PHARMACEUTICAL INC (BMRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan Lewis has been a net seller of BMRN stock. They have purchased $0 and sold $7.3M worth of shares.
Alan Lewis's most recent insider trade was on Jun 4, 2019, when they sold 4,430 shares at $0.00 per share.
Alan Lewis serves as Executive at BIOMARIN PHARMACEUTICAL INC (BMRN). They have executed 51 insider transactions totaling $7.3M over their tenure at the company.
Alan Lewis holds the position of Executive at BIOMARIN PHARMACEUTICAL INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Alan Lewis has shown a selling trading pattern, with $0 in total purchases and $7.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alan Lewis was on Dec 9, 2013, when they sold $1.6M worth of BMRN shares. This transaction involved 22,500 shares at $69.91 per share.
Alan Lewis currently owns 25,590 shares of BIOMARIN PHARMACEUTICAL INC (BMRN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alan Lewis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alan Lewis has 51 Form 4 filings on record as an insider at BIOMARIN PHARMACEUTICAL INC.
Set alerts for Alan Lewis and 40,000+ other insiders.